US Broker Ratings

Quantum-Si Incorporated (QSI) Stock Analysis: Exploring a 60.98% Potential Upside in the Healthcare Sector

In the dynamic landscape of the healthcare industry, Quantum-Si Incorporated (NASDAQ: QSI) stands out as an innovative player in the medical devices sector. With a market capitalization of $322.96 million,..

AMTD Digital Inc. (HKD) Stock Analysis: Navigating Challenges Amidst the Digital Economy

AMTD Digital Inc. (HKD), a Paris-headquartered technology company, operates within the dynamic Software – Application industry. Despite its expansive reach across Europe, the United States, Hong Kong, Singapore, and Asia,..

Health Catalyst, Inc. (HCAT) Stock Analysis: A Promising 88% Potential Upside for Investors

Investors looking for a compelling opportunity in the healthcare sector may find Health Catalyst, Inc. (NASDAQ: HCAT) an intriguing prospect. With a market capitalization of $275.62 million, Health Catalyst operates..

Erasca, Inc. (ERAS) Stock Analysis: Exploring a Potential 280% Upside in Biotechnology

Erasca, Inc. (NASDAQ: ERAS) is making waves in the biotechnology sector, offering investors a compelling opportunity in the ever-evolving landscape of precision oncology. As a San Diego-based clinical-stage company, Erasca..

Palvella Therapeutics, Inc. (PVLA) Stock Analysis: A Lucrative Opportunity with 94% Upside Potential

For investors with an eye towards biotechnology, Palvella Therapeutics, Inc. (PVLA) represents a tantalizing opportunity in the healthcare sector. With its focus on rare genetic skin diseases, Palvella is at..

Viemed Healthcare, Inc. (VMD) Stock Analysis: Exploring a Potential 74% Upside

Viemed Healthcare, Inc. (NASDAQ: VMD) presents an intriguing opportunity for investors looking to delve into the healthcare sector, specifically within the niche of medical devices and respiratory healthcare services. Based..

Fair Isaac Corporation (FICO) Stock Analysis: Exploring a 21.69% Potential Upside for Investors

Fair Isaac Corporation (NYSE: FICO) is a behemoth in the technology sector with a remarkable market capitalization of $43.94 billion. Renowned for its pioneering role in analytics and digital decisioning..

Tvardi Therapeutics, Inc. (TVRD) Investor Outlook: A 93.55% Potential Upside in Biotechnology

Tvardi Therapeutics, Inc. (TVRD) is commanding attention in the biotechnology sector with a compelling narrative for investors. Based in Sugar Land, Texas, Tvardi is a biotechnology company focused on developing..

Neuronetics, Inc. (STIM) Investor Outlook: Unveiling a Compelling 78.88% Potential Upside

Neuronetics, Inc. (NASDAQ: STIM) is capturing the attention of the healthcare investment community with a promising potential upside of 78.88%. This medical device company, specializing in neurohealth treatments, is making..

Cidara Therapeutics (CDTX) Investor Outlook: A 61.97% Potential Upside in Biotech Innovation

Cidara Therapeutics, Inc. (CDTX), headquartered in San Diego, California, is a biotechnology company carving its niche in the healthcare sector by targeting serious diseases like cancer and invasive fungal infections...

Senseonics Holdings, Inc. (SENS): Investor Outlook with a 196.71% Potential Upside

Senseonics Holdings, Inc. (SENS), a pioneering entity in the healthcare sector, is drawing attention with its remarkable potential upside of 196.71%. Headquartered in Germantown, Maryland, Senseonics is a commercial-stage medical..

ClearPoint Neuro Inc. (CLPT): Investor Outlook with a Promising 125% Upside Potential

ClearPoint Neuro Inc. (NASDAQ: CLPT) is capturing the attention of investors with its innovative approach to medical devices in the healthcare sector, particularly in the realm of minimally invasive brain..

Alpha Teknova, Inc. (TKNO) Stock Analysis: Exploring an 84% Potential Upside in the Healthcare Sector

Alpha Teknova, Inc. (NASDAQ: TKNO) is capturing investor attention with its substantial potential upside. With a market cap of $319.04 million, this California-based healthcare company operates within the specialty and..

Pacific Biosciences of California (PACB) Stock Analysis: Investors Eye 81% Potential Upside

Pacific Biosciences of California, Inc. (NASDAQ: PACB), a prominent player in the healthcare sector specializing in medical devices, presents a compelling opportunity for investors seeking exposure to the burgeoning field..

Spok Holdings, Inc. (SPOK) Stock Analysis: A Healthcare Communication Leader with a 20% Upside

Investors looking for opportunities in the healthcare sector may want to keep an eye on Spok Holdings, Inc. (NASDAQ: SPOK), a company that specializes in health information services. With a..

Cartesian Therapeutics, Inc. (RNAC) Stock Analysis: Exploring a Promising 247% Upside Potential

Cartesian Therapeutics, Inc. (NASDAQ: RNAC) is capturing investor attention with an intriguing confluence of clinical potential and financial metrics. As a clinical-stage biotechnology firm, Cartesian Therapeutics is pioneering the development..

Olema Pharmaceuticals, Inc. (OLMA) Stock Analysis: A Promising Biotech with Over 500% Potential Upside

Olema Pharmaceuticals, Inc. (NASDAQ: OLMA) stands out in the biotechnology sector with a focus on developing innovative therapies for women’s cancers. Despite its current modest market cap of $279.16 million..

Aura Biosciences, Inc. (AURA) Stock Analysis: A 224% Potential Upside in the Biotech Sector

Aura Biosciences, Inc. (AURA), a clinical-stage biotechnology company, is capturing attention with a striking potential upside of 224.28%. This figure, derived from the average target price of $21.50 against its..

Quhuo Limited (QH) Investor Outlook: Navigating Challenges with a 52-Week High Potential

Quhuo Limited (QH), a notable player in the gig economy space in China, presents a complex yet intriguing profile for investors keen on the technology sector. With its headquarters in..

Nerdy Inc. (NRDY) Stock Analysis: Navigating Challenges and Opportunities in the Online Learning Sector

Nerdy Inc. (NRDY), a prominent player in the online learning industry, is navigating a complex financial landscape. With a market capitalization of $331.5 million, the company operates in the technology..

US Broker Ratings

US Broker Ratings

FTSE 100

Funds